{
  "Variants Include": [
    {
      "Gene": "SLC13A5",
      "variants": [
        {
          "HGVS": "NM_001134553.1:c.189G>T",
          "cDNA Change": {
            "transcript": "NM_001134553.1",
            "ref": "G",
            "alt": "T",
            "position": "189"
          },
          "Protein Change": {
            "ref": "E",
            "alt": "D",
            "position": "64"
          },
          "Description in input context": "E64D mutation in SLC13A5 gene"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Bartter syndrome type 3",
    "MONDO": "MONDO:0008106"
  },
  "Experiment Method": [
    {
      "Assay Method": "Patch-clamp electrophysiology",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293",
        "Description": "HEK293 cells expressing wild-type and E64D mutant SLC13A5 were used."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001134553.1:c.189G>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "E64D mutation significantly increased sodium-dependent dicarboxylate transport currents by 60% compared to wild-type."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three independent biological replicates were performed."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each cell was recorded in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type SLC13A5-expressing cells were used as positive controls."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector-transfected HEK293 cells were used as negative controls."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "3"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "Yes",
        "Counts": "2"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Two-tailed Student's t-test was used for statistical analysis."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Transport current amplitude within 20% of wild-type control",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Transport current amplitude exceeding 30% of wild-type control",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Western blot",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "CHO cells",
        "Description": "CHO cells stably expressing wild-type and E64D mutant SLC13A5 were analyzed."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001134553.1:c.189G>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "No significant change in protein expression",
          "Result Description": "E64D mutation did not alter SLC13A5 protein expression levels compared to wild-type."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Four independent biological replicates were performed."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was run in duplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type SLC13A5-expressing CHO cells were used as positive controls."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Untransfected CHO cells were used as negative controls."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "Yes",
        "Counts": "1"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "One-way ANOVA with post-hoc Tukey's test was used."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Protein expression within 15% of wild-type control",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Protein expression deviating by more than 25% from wild-type control",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Cell viability assay (MTT)",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293",
        "Description": "HEK293 cells expressing wild-type and E64D mutant SLC13A5 were subjected to viability testing."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001134553.1:c.189G>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "No significant change in cell viability",
          "Result Description": "E64D mutation did not significantly affect cell viability compared to wild-type."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three independent biological replicates were performed."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was tested in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type SLC13A5-expressing HEK293 cells were used as positive controls."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Untransfected HEK293 cells were used as negative controls."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "3"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "Yes",
        "Counts": "2"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Two-way ANOVA with Bonferroni correction was used."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Cell viability within 10% of wild-type control",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Cell viability deviating by more than 20% from wild-type control",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}